Tag
Hemant Amrish Parikh
2 articles
Vivanza Biosciences FY26 Net Loss ₹96.54 Lakhs Standalone
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting a standalone net loss of ₹96.54 lakhs for the year.
Noted resignations of Non-Executi
Vivanta Industries Promoters Disclose FY26 Holdings
Multiple promoters of Vivanta Industries filed regulatory disclosures confirming their shareholdings as of March 31, 2026.
The filings pursuant to SEBI SAST Regulation 31(4) declare no share encumbran